Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
Li JT, Lu Y, Hou J, Chen YF, Miao JZ, Jia YX, Hou J, Zhang XZ, Chen DK, Hu WZ, Li LJ, Liu DM, Wang Z, Wu J, Gu JM, Wang HL, Zhang YL, Sun L.
Li JT, et al. Among authors: lu y.
Clin Infect Dis. 1997 Mar;24(3):498-505. doi: 10.1093/clinids/24.3.498.
Clin Infect Dis. 1997.
PMID: 9114206
Clinical Trial.